ask="7.50"
ask_size="100"
average_daily_volume="338908"
bid="N/A"
bid_size="N/A"
book_value="3.74"
change="+0.17"
change_from_200_day_moving_average="1.34"
change_from_50_day_moving_average="-0.16"
change_from_52_week_high="-2.67"
change_From_52_week_low="3.23"
change_in_percent="+4.38%"
close="4.05"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13899000"
high="4.07"
high_52_weeks="6.72"
last_trade_date="2/24/2017"
last_trade_price="4.05"
last_trade_size="8398"
last_trade_time="4:00pm"
low="3.70"
low_52_weeks="0.82"
market_capitalization="91.33M"
moving_average_200_day="2.71"
moving_average_50_day="4.21"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="3.84"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+49.62%"
percent_change_from_50_day_moving_average="-3.86%"
percent_change_from_52_week_high="-39.73%"
percent_change_from_52_week_low="+393.90%"
previous_close="3.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.04"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="2.62"
stock_exchange="NMS"
symbol="CASC"
volume="276458"
weeks_range_52="0.82 - 6.72"
